L Donner
Impact in
- Neurology top 10%
- Neuroinflammation and Neurodegeneration Mechanisms
- Neuroblastoma Research and Treatments
- Neurological Disorders and Treatments
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research
Papers in ⓘ
-
- Platelet Disorders and Treatments 5
-
- Advanced Glycation End Products research 4
- Co-authors
- Margitta Elvers (10 shared papers)Martin Schaller (4 shared papers)Nina Sarah Gowert (4 shared papers)Oliver Borst (2 shared papers)Patrick Münzer (2 shared papers)Florian Läng (2 shared papers)Lothar Gremer (3 shared papers)Dieter Willbold (3 shared papers)
In The Last Decade
L Donner
29 papers receiving 546 citations
Peers
Comparison fields: 5 of 78
- Neurology 126
- Clinical Biochemistry 79
- Hematology 106
- Physiology 206
- Neurology 106
Countries citing papers authored by L Donner
This map shows the geographic impact of L Donner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Donner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Donner more than expected).
Fields of papers citing papers by L Donner
This network shows the impact of papers produced by L Donner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Donner. The network helps show where L Donner may publish in the future.
Co-authors
The 25 scholars most cited alongside L Donner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 109 | |
| 2 | 2016 | 92 | |
| 3 | Biological classification of cell lines derived from human extra-cranial neural tumors. | 1988 | 79 |
| 4 | 2014 | 63 | |
| 5 | 2023 | 30 | |
| 6 | 2021 | 23 | |
| 7 | 2017 | 21 | |
| 8 | 2020 | 20 | |
| 9 | 2018 | 17 | |
| 10 | 2017 | 16 | |
| 11 | 1961 | 11 | |
| 12 | 1974 | 10 | |
| 13 | 1977 | 10 | |
| 14 | 1972 | 9 | |
| 15 | 1962 | 7 | |
| 16 | Daunorubicin and adriamycin in the treatment of leukemia. | 1973 | 6 |
| 17 | 2024 | 4 | |
| 18 | 1977 | 4 | |
| 19 | 1967 | 4 | |
| 20 | Use of vinblastine for maintenance therapy in malignant lymphomas. | 1974 | 4 |
About L Donner
L Donner is a scholar working on Hematology, Clinical Biochemistry, Genetics, Physiology and Oncology, having authored 33 papers that have together received 560 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (7 papers), Platelet Disorders and Treatments (5 papers), Cancer Treatment and Pharmacology (4 papers), Advanced Glycation End Products research (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers) and Kruppel-like factors research (2 papers). The work is most often cited by research in Neurology (126 citations), Clinical Biochemistry (79 citations), Hematology (106 citations), Physiology (206 citations) and Neurology (106 citations). L Donner has collaborated with scholars based in Germany, Czechia and Norway. Frequent co-authors include Margitta Elvers, Martin Schaller, Nina Sarah Gowert, Oliver Borst, Patrick Münzer, Florian Läng, Lothar Gremer, Dieter Willbold, Seeger Rc and C. Patrick Reynolds. Their work appears in journals such as Thrombosis and Haemostasis, Cellular Signalling, Science Signaling, International Journal of Molecular Sciences and Acta Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.